AbbVie Inc.ABBVNYSE
Loading
Year-over-year book value per share growth
Percentile
P21
Within normal range
vs 3Y Ago
-3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -23.62% |
| Q3 2025 | -1783.33% |
| Q2 2025 | -109.42% |
| Q1 2025 | -56.52% |
| Q4 2024 | -44.59% |
| Q3 2024 | -11.00% |
| Q2 2024 | -15.24% |
| Q1 2024 | -22.74% |
| Q4 2023 | -14.23% |
| Q3 2023 | -5.96% |
| Q2 2023 | -2.88% |
| Q1 2023 | -23.08% |
| Q4 2022 | 7.97% |
| Q3 2022 | 9.05% |
| Q2 2022 | -9.92% |
| Q1 2022 | 5.53% |
| Q4 2021 | 13.80% |
| Q3 2021 | 7.74% |
| Q2 2021 | -8.29% |
| Q1 2021 | 4.86% |
| Q4 2020 | -14.34% |
| Q3 2020 | -3.38% |
| Q2 2020 | 278.65% |
| Q1 2020 | 9.39% |
| Q4 2019 | 0.52% |
| Q3 2019 | 4.03% |
| Q2 2019 | -9.46% |
| Q1 2019 | 7.26% |
| Q4 2018 | -194.94% |
| Q3 2018 | 10.19% |
| Q2 2018 | -196.38% |
| Q1 2018 | -30.24% |
| Q4 2017 | -23.54% |
| Q3 2017 | 11.14% |
| Q2 2017 | 20.38% |
| Q1 2017 | 7.51% |
| Q4 2016 | -26.56% |
| Q3 2016 | 14.14% |
| Q2 2016 | 20.87% |
| Q1 2016 | 17.25% |